Contract Research

Contact Us
Tergene's Research & In-House Technologies

Tergene's R&D team have a rich experience in the field of biotechnology with individual achievements. Tergene believes that their rich expertise is an asset to the company. The technologies under development would contribute a lot to the company's growth and achievement.

Technologies Developed

We have successfully developed technologies for the production of various vaccines and biosimilars. Acellular Pertussis (ACP) vaccine, Haemophilus influenzae type B (HiB) conjugated vaccine, Typhoid Vaccine, Streptokinase, Terinase - a thrombolytic enzyme are some of the technologies.

A multivalent Pneumococcal vaccine is currently under advanced stage of development.


 Disclaimer          Environment and Health Risk Management Plan            2018 All Rights Reserved with Tergene Biotech